GM-CSF Clinical Trials
8 recruitingDrug
Phase 26Phase 12
Showing 1–8 of 8 trials
Recruiting
Phase 1
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
LymphomaLeukemiaHodgkin Disease+4 more
Medical College of Wisconsin42 enrolled1 locationNCT05544968
Recruiting
Phase 2
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium62 enrolled13 locationsNCT06450041
Recruiting
Phase 2
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
Neuroblastoma
Memorial Sloan Kettering Cancer Center286 enrolled1 locationNCT04936529
Recruiting
Phase 2
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
Interstitial Lung DiseasePulmonary HypertensionSystemic Sclerosis+1 more
Paul Szabolcs8 enrolled3 locationsNCT03630211
Recruiting
Phase 1
A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma
Multiple MyelomaRefractory Multiple MyelomaRelapse Multiple Myeloma
David Avigan25 enrolled2 locationsNCT06799026
Recruiting
Phase 2
Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma
Neuroblastoma
Sun Yat-Sen University Cancer Center120 enrolled1 locationNCT06013618
Recruiting
Phase 2
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
Peripheral Artery Disease (PAD)
Emory University176 enrolled1 locationNCT03304821
Recruiting
Phase 2
The Effect of GM-CSF to Preventing Oral Mucositis for Patients With Nasopharyngeal Carcinoma Receiving Radiotherapy
GM-CSF
Sun Yat-sen University138 enrolled1 locationNCT06472739